Immunomedics Inc (IMMU) - Medical Equipment - Deals and Alliances Profile
December 2018
44
About the Report
About the Report
Summary
Immunomedics Inc (Immunomedics) is a clinical-stage bio-pharmaceutical company that researches, develops, manufactures and commercializes monoclonal antibody-based drugs for the treatment of cancer and autoimmune disorders. The company develops its candidates based on its proprietary technologies namely, ADC Linker technology and Dock-And-Lock platform. Its lead product candidate is Sacituzumab govitecan (IMMU-132) in Phase II development stage received breakthrough therapy designation from the US FDA for the treatment of patients with metastatic triple-negative breast cancer and metastatic solid cancers. Immunomedics' other lead product candidates include Labetuzumab Govitecan (IMMU-130) and Epratuzumab. It also has other product candidates that target solid tumors, hematologic malignancies and other diseases, in various stages of clinical and pre-clinical development. The company also manufactures and commercializes diagnostic imaging product named, LeukoScan. Immunomedics is headquartered in Morris Plains, New Jersey, the US.
Immunomedics Inc (IMMU)-Medical Equipment-Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.
GlobalData derived the data presented in this report from proprietary in-house Medical eTrack deals database, and primary and secondary research.
Scope
- Financial Deals-Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year-Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type-Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region-Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector-Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals-Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description-A brief description of the company's operations.
- Key Employees-A list of the key executives of the company.
- Important Locations and Subsidiaries-A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors-A list of the key competitors of the company.
- Key Recent Developments-A brief on recent news about the company.
Reasons to Buy
Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.
Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.
Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.
Equip yourself with detailed information about the company's operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.
Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.
Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.
Note*: Some sections may be missing if data is unavailable for the company.
Products
Products
Immunomedics Inc, Deal Analysis, Mergers, Acquisitions, Asset Purchases, Asset Divestitures, Company Divestitures, Equity Offerings, Capital Raising, Debt Offerings, IPOs, Initial Public Offering, Private Placement, Private Investment In Public Equities, Secondary Offerings, Follow-On Offerings, Debt Private Placement, Public Debt Placement, Partnerships, Joint Venture, Licensing Agreements, Co-Marketing Agreements, Upfront Payment, Milestone Payment, Phases, Clinical Trials, Private Equity, Venture Capital, PE,VC, Asset Finance, Project Finance, Tax Equity Financing, Bond Financing, Lease Financing, New Build Financing, Deal Analysis By Market/sector, Deal Analysis By Geography, Deal Analysis By Deal Types, Key Employees, Locations And Subsidiaries, Competitors, Recent News, Company Overview, Key Facts, Deals By Year, Deal Details, Recent Developments, Significant Developments.
Table of Contents
Table of Contents
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Immunomedics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Immunomedics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Immunomedics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Immunomedics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 8
Immunomedics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immunomedics Inc, Medical Equipment, Deal Details 10
Equity Offering 10
Immunomedics Raises USD276 Million in Public Offering of Shares 10
Immunomedics to Raise USD75 Million in Private Placement of Shares 12
Immunomedics Plans to Raise Funds through Public Offering of Shares 14
Immunomedics Completes Public Offering Of Shares For USD 30.2 Million 15
Immunomedics Completes Public Offering Of Common Stock For USD 16 Million 17
Debt Offering 18
Immunomedics Raises USD85 Million in Private Placement of 4.75% Notes Due 2020 18
Immunomedics Inc-Key Competitors 20
Immunomedics Inc-Key Employees 21
Immunomedics Inc-Locations And Subsidiaries 22
Head Office 22
Other Locations & Subsidiaries 22
Recent Developments 23
Financial Announcements 23
Nov 07, 2018: Immunomedics announces first quarter fiscal 2019 results and provides corporate update 23
Aug 23, 2018: Immunomedics announces fourth quarter and fiscal year 2018 results and provides corporate update 25
May 09, 2018: Immunomedics Announces Third Quarter Fiscal 2018 Results and Provides Corporate Update 27
Feb 08, 2018: Immunomedics Announces Second Quarter Fiscal 2018 Results and Provides Corporate Update 29
Nov 09, 2017: Immunomedics Announces First Quarter Fiscal 2018 Results and Provides Corporate Update 31
Aug 16, 2017: Immunomedics Announces Fiscal 2017 Results and Strategic Developments; Reiterates Guidance on BLA Submission Timeline 33
May 10, 2017: Immunomedics Announces Third Quarter Fiscal 2017 Results And Clinical Program Developments 35
Feb 09, 2017: Immunomedics Announces Second Quarter Fiscal 2017 Results and Clinical Program Developments 37
Corporate Communications 39
Apr 09, 2018: Immunomedics Appoints Dr. Robert Iannone Head of Research & Development and Chief Medical Officer 39
Jan 09, 2017: Immunomedics Announces Reconstituted Board of Directors and Leadership Succession Plan 40
Government and Public Interest 41
May 05, 2017: Immunomedics Delivers Business Updates, Announces Private Placement Offering and Outlines Strategic Steps to Drive Stockholder Value 41
Appendix 44
Methodology 44
About GlobalData 44
Contact Us 44
Disclaimer 44
List of Figure
List of Figures
Immunomedics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 2
Immunomedics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 2
Immunomedics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 2
Immunomedics Inc, Medical Equipment, Deals By Market, 2012 to YTD 2018 2
Immunomedics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Immunomedics Inc, Medical Equipment, Deals by Type, 2012 to YTD 2018 6
Immunomedics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Immunomedics Inc, Medical Equipment, Deals by Market, 2012 to YTD 2018 8
List of Table
List of Tables
Immunomedics Inc, Medical Equipment, Key Facts, 2018 2
Immunomedics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 2
Immunomedics Inc, Medical Equipment, Deals By Year, 2012 to YTD 2018 5
Immunomedics Inc, Medical Equipment Deals By Type, 2012 to YTD 2018 6
Immunomedics Inc, Medical Equipment, Deals By Region, 2012 to YTD 2018 7
Immunomedics Inc, Deals By Market, 2012 to YTD 2018 8
Immunomedics Inc, Medical Equipment, Deals Summary, 2012 to YTD 2018 9
Immunomedics Raises USD276 Million in Public Offering of Shares 10
Immunomedics to Raise USD75 Million in Private Placement of Shares 12
Immunomedics Plans to Raise Funds through Public Offering of Shares 14
Immunomedics Completes Public Offering Of Shares For USD 30.2 Million 15
Immunomedics Completes Public Offering Of Common Stock For USD 16 Million 17
Immunomedics Raises USD85 Million in Private Placement of 4.75% Notes Due 2020 18
Immunomedics Inc, Key Competitors 20
Immunomedics Inc, Key Employees 21
Immunomedics Inc, Subsidiaries 22
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.